For a 109‑kg (BMI 35) patient with hemoglobin A1c 8.0 % and hemoglobin 8.2 g/dL who is not on insulin at home and received dexamethasone 20 mg 24 hours ago (and will receive another dose today), what starting dose of insulin glargine (Lantus), carbohydrate‑to‑insulin ratio, and correction factor should be used?

Insulin Management for Steroid-Induced Hyperglycemia

For this 109-kg patient with A1c 8.0% receiving dexamethasone 20 mg daily, start NPH insulin 22 units in the morning (0.2 units/kg/day), use a carbohydrate ratio of 1:10 grams, and apply a correction factor of 1 unit per 30 mg/dL above 150 mg/dL.

Rationale for NPH Over Lantus in Steroid-Induced Hyperglycemia

The 2025 American Diabetes Association guidelines specifically recommend NPH insulin dosed in the morning for steroid-induced hyperglycemia rather than long-acting basal analogs like Lantus 1. This is critical because dexamethasone causes peak hyperglycemia in the afternoon (typically 2-3 PM), not overnight 2. NPH's intermediate duration of action (peak at 4-8 hours) better matches the glycemic pattern induced by morning dexamethasone administration 1.

Starting Insulin Dose

Basal Insulin Calculation

• Start with 0.2 units/kg/day of NPH insulin given in the morning 1
• For this 109-kg patient: 0.2 × 109 = 22 units NPH in the morning
• This patient's A1c of 8.0% places them in the moderate hyperglycemia category, supporting this starting dose 3

Evidence Supporting This Dose

The 2023 research on dexamethasone-induced hyperglycemia stratified by A1c showed that patients with A1c 8-8.9% required median insulin doses of 0.66 units/kg/day by day 10 of dexamethasone therapy 4. However, starting conservatively at 0.2 units/kg/day and titrating upward reduces hypoglycemia risk while allowing for dose escalation as needed 1.

Carbohydrate Ratio

Start with a 1:10 carbohydrate-to-insulin ratio (1 unit of rapid-acting insulin per 10 grams of carbohydrate) for prandial coverage 5. This is a standard starting point for insulin-naive patients with moderate glycemic control.

Prandial Insulin Initiation

• Add 4 units of rapid-acting insulin before the largest meal (typically lunch or dinner when steroid effect peaks) 1
• Alternatively, use 10% of the basal dose (2-3 units in this case) if starting more conservatively 1
• The 2025 ADA guidelines recommend starting prandial insulin with the meal showing greatest postprandial glucose excursion 1

Correction Scale (Insulin Sensitivity Factor)

Use a correction factor of 1 unit per 30 mg/dL above target glucose of 150 mg/dL for pre-meal corrections.

Correction Insulin Dosing

• Target fasting plasma glucose: 90-150 mg/dL 1
• For glucose >250 mg/dL: give 2 units rapid-acting insulin 6
• For glucose >350 mg/dL: give 4 units rapid-acting insulin 6
• Titrate by increasing 2 units every 3 days if 50% of fasting glucose values exceed goal 1

Critical Considerations for Dexamethasone-Induced Hyperglycemia

Timing of Hyperglycemia

Research demonstrates that dexamethasone causes peak glucose elevation 2-3 PM (mean peak 128-144 mg/dL in young patients, higher in those with diabetes) 2. A second smaller peak occurs before sleep 2. This afternoon peak pattern makes morning NPH superior to evening Lantus 1.

Risk Factors in This Patient

• A1c 8.0% is the strongest predictor of postoperative glucose control and dexamethasone-induced hyperglycemia 7, 8
• Patients with A1c 8-8.9% developed hyperglycemia in 100% of cases with dexamethasone 4
• Hemoglobin 8.2 g/dL indicates anemia, which may affect A1c reliability and requires consideration 4

Dose Escalation Strategy

Based on the 2023 COVID-19 dexamethasone study, patients with A1c 8-8.9% ultimately required 0.66 units/kg/day (approximately 72 units total for this patient) by day 10 4. Plan for aggressive titration as this patient will likely need substantial dose increases over the first week.

Hypoglycemia Prevention

Critical Warning About Dexamethasone Discontinuation

25% of patients experienced hypoglycemia (glucose <70 mg/dL) upon dexamethasone discontinuation 4. Additionally, 35% of young patients on high-dose steroids experienced early morning hypoglycemia 2.

Dose Reduction Protocol

• Reduce insulin dose by 10-20% if hypoglycemia occurs without clear cause 1
• When dexamethasone is discontinued, reduce total insulin dose by 35-50% to prevent rebound hypoglycemia 1
• Monitor closely for 24-48 hours after steroid cessation 4

Monitoring and Titration

Glucose Monitoring Schedule

• Check fasting glucose daily to titrate morning NPH dose 1
• Check pre-lunch and pre-dinner glucose to assess adequacy of NPH coverage during peak steroid effect 6
• Increase NPH by 2 units every 3 days if fasting glucose remains above 150 mg/dL 1

Signs of Inadequate Basal Coverage

Watch for elevated bedtime-to-morning differential or postprandial-to-preprandial differential, which indicate need for dose adjustment or additional prandial insulin 1

Alternative Considerations

If NPH Causes Hypoglycemia

Consider switching to basal analog (Lantus) dosed in the morning if the patient develops recurrent hypoglycemia with NPH 1. However, this is a second-line approach for steroid-induced hyperglycemia.

Weight-Based Insulin Safety

Research shows that insulin doses >0.6 units/kg/day significantly increase hypoglycemia risk (odds ratio 2.10-2.95) 9. This patient may ultimately require doses approaching this threshold given their A1c, necessitating careful monitoring.

Renal Considerations

The patient's hemoglobin of 8.2 g/dL raises concern for possible chronic kidney disease. Renal impairment increases insulin levels and hypoglycemia risk, requiring potential dose reductions 10.